Laurion Capital Management LP G1 Therapeutics, Inc. Transaction History

Laurion Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.57 - $8.16 $445,496 - $1.41 Million	-173,345 Reduced 86.67%	26,655 $71,000
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $1.04 Million - $2.7 Million	200,000 New	200,000 $1.09 Million
Q2 2022 Aug 15, 2022	BUY	$4.04 - $8.51 $51,130 - $107,702	12,656 New	12,656 $63,000
Q4 2018 Feb 14, 2019	SELL	$16.51 - $51.33 $1.82 Million - $5.66 Million	-110,348 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$43.15 - $67.97 $4.76 Million - $7.5 Million	110,348 New	110,348 $5.77 Million
Q2 2018 Aug 13, 2018	SELL	$35.06 - $51.17 $1.19 Million - $1.74 Million	-34,016 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$19.05 - $41.76 $648,004 - $1.42 Million	34,016 New	34,016 $1.26 Million
Q4 2017 Feb 13, 2018	SELL	$19.01 - $26.2 $3.8 Million - $5.24 Million	-200,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$12.53 - $27.12 $2.51 Million - $5.42 Million	200,000	200,000 $4.98 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.